Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: DermaVirBiological: PlaceboDrug: HAART
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 16
- Registration Number
- NCT00918840
- Locations
- 🇮🇹
IRCCS Policlinico S. Matteo, Pavia, Italy
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: DermaVirDrug: HAART
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 9
- Registration Number
- NCT00712530
- Locations
- ðŸ‡ðŸ‡º
Saint Laszlo Hospital, Budapest, Hungary
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
Phase 2
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: DermaVirBiological: Placebo
- First Posted Date
- 2008-07-08
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 36
- Registration Number
- NCT00711230
- Locations
- 🇩🇪
ifi-Medizin GmbH at the Asklepios Klinik St. Georg, Hamburg, Germany
🇩🇪ICH Grindel, Hamburg, Germany
🇩🇪University Medical Center Hamburg-Eppendorf, Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath